cefuroxime has been researched along with cefaclor anhydrous in 90 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (26.67) | 18.7374 |
1990's | 35 (38.89) | 18.2507 |
2000's | 18 (20.00) | 29.6817 |
2010's | 13 (14.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Loch, R; Schröter, G | 2 |
Braveny, I; Dickert, H; Machka, K | 1 |
Johnson, DM; Jones, RN | 1 |
Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Pfaller, MA; Washington, JA | 1 |
Bingen, E; Bourgeois, F; Chardon, H; Doit, C; Lambert-Zechovsky, N | 1 |
Barry, AL; Doern, GV; Ferraro, MJ; Jorgensen, JH; Murray, PR | 1 |
Burton, DM; Kearns, DB; Pransky, SM; Seid, AB | 1 |
Pelletier, LL | 1 |
Ducroix, JP; Gaudio, F; Laurans, G; Orfila, J | 1 |
Collins, JJ; Davis, IM; Donn, KH; Hart, RW; James, NC; Lloyd, TL; Powell, JR | 1 |
Fukuoka, F; Hara, H; Kaneko, A; Michi, K; Morihana, T; Ohne, M; Sasaki, I; Satoh, T; Takahashi, K; Yoshinari, N | 1 |
Buchanan, GR; Morrison, RA; Rogers, ZR; Vedro, DA | 1 |
Aronovitz, GH; Darden, PM; Gooch, WM; Johnson, C; Maddern, B; McLinn, SE; Pichichero, M | 1 |
Bergeron, MG; L'Ecuyer, J; Provencher, P; Tremblay, LD | 1 |
Derriennic, M; Dubreuil, L; Sedallian, A | 1 |
Cocchetto, DM; Gwaltney, JM; Scheld, WM; Sydnor, A | 1 |
Shelton, MM; Welch, DF | 1 |
Iravani, A; Richard, GA | 1 |
Aronovitz, GH | 1 |
Beskid, G; Durkin, JW; Fallat, V; Lipschitz, ER; McGarry, DH; Siebelist, J | 1 |
Claeys, G; Van den Abeele, AM; Verschraegen, G | 1 |
Barry, AL; Jones, RN | 1 |
Chin, NX; Neu, HC | 1 |
Anthony, WC; Craig, W; File, TM; Lifland, P; Schleupner, CJ; Tan, J; Vogelman, B | 1 |
Knapp, CC; Washington, JA | 1 |
Gezelius, L; Liljequist, BO | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN | 1 |
Barson, WJ; Brady, MT; Cannon, HJ; Grossman, LK | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN; Thornsberry, C | 1 |
Brown, GW; Cox, DM; Hebblethwaite, EM; Plested, SJ; Williams, KJ | 1 |
Aznar, J; Borobio, MV; Garcia, F; Jimenez, R; Perea, EJ | 1 |
Bianchi, P; Frongillo, RF | 1 |
Forsgren, A; Walder, M | 1 |
Weinstein, AJ | 1 |
Bucholz, RW; Kusmiesz, H; Nelson, JD; Shelton, S | 1 |
Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
Ball, P | 1 |
Garcia Iglesias, MC; Perea, EJ | 1 |
Dagan, R; Liss, Z; Shvartzman, P | 1 |
Asikainen, S; Forsblom, B; Jousimies-Somer, H; Pajukanta, R; Piekkola, M | 1 |
Alaluusua, S; Asikainen, S; Jousimies-Somer, H; Pajukanta, R; Saarela, M | 1 |
Liston, TE | 1 |
Issopoulos, PB; Salta, SE | 1 |
Aleo, G; Blandino, G; Caccamo, F; Nicolosi, VM; Siracusa, V; Speciale, A | 1 |
Carpentier, M; Delmée, M; Glupczynski, Y; Gordts, B; Magerman, K; Simon, A; Surmont, I; Van de Vyvere, M; Van Landuyt, H; Van Nimmen, L; Van Noyen, R | 1 |
Gürses, N; Islek, I; Kalayci, AG; Uysal, S | 1 |
Abramson, O; Dagan, R; Fliss, DM; Goshen, S; Greenberg, D; Lang, R; Leiberman, A; Leibovitz, E; Yagupsky, P | 2 |
Bermejo, M; García-de-Lomas, J; García-Ponte, L; Garijo, B; Gimeno, C; Lázaro, MA; Millás, E; Navarro, D | 1 |
Brookings, E; Gray, B; Swiatlo, E; Waites, K | 1 |
Goldstein, FW | 1 |
Verbist, L; Verhaegen, J | 1 |
Johns, D; Turik, MA | 1 |
Preston, D; Therasse, D; Zeckel, ML | 1 |
Gould, IM; Mackenzie, FM; Milne, KE | 3 |
Kitayama, R; Minami, S; Mitsuyama, J; Watanabe, Y; Yamada, H | 1 |
Furudoi, S; Komori, T; Ohtsuka, Y; Yoshii, T; Yoshikawa, T; Yoshioka, A | 1 |
Chyczewska, E; Grzelewska-Rzymowska, I; Haczyński, J; Malolepszy, J; Marcinkowska-Suchowierska, E; Milanowski, J; Oklek, K; Płusa, T; Rek, M; Szmygin, K; Słominski, J | 1 |
Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
Jakoniuk, P; Leszczyńska, K; Sacha, PT; Wieczorek, P; Zalewska, M | 1 |
Hutchison, J; Nolen, TM; Phillips, HL | 1 |
Hur, JK; Kang, JH; Kim, JH; Lee, KY; Lee, SY | 1 |
Chen, D; Song, Z; Wang, Z | 1 |
Erikstrup, LT; Fuursted, K; Nørskov-Lauritsen, N; Ridderberg, W | 1 |
Biscaro, V; Caruso, A; De Francesco, MA; Gargiulo, F; Piccinelli, G | 1 |
Balsamo, A; Barontini, S; Calvani, F; Di Modugno, E; Felici, A; Gentili, D; Macchia, M; Rossello, A | 1 |
Brandsch, M; Luckner, P | 1 |
Biegel, A; Brandsch, M; Gebauer, S; Hartrodt, B; Neubert, K; Thondorf, I | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Ki, CS; Kim, IS; Kim, S; Lee, K; Lee, NY; Oh, WS; Peck, KR; Song, JH | 1 |
Campos, J; Cercenado, E; de Abajo, F; García-Cobos, S; García-Rey, C; Lázaro, E; Oteo, J; Pérez-Vázquez, M; Román, F | 1 |
Billal, DS; Hotomi, M; Yamanaka, N | 1 |
Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Aguilar, L; Alou, L; Cafini, F; Cercenado, E; Coronel, P; Gené, A; Giménez, MJ; Marco, F; Martínez-Martínez, L; Sevillano, D | 1 |
Miriagou, V; Papagiannitsis, CC; Tzouvelekis, LS | 1 |
Kotsakis, SD; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Distèche-Nguyen, M; Gerards, T; Luxen, A; Miguet, L; Pasha, FA; Thomas, A; Zervosen, A | 1 |
Bae, S; Kang, Y; Kim, E; Lee, J; Lee, S; Yu, J | 1 |
Kotsakis, SD; Legakis, NJ; Miriagou, V; Papagiannitsis, CC; Tzelepi, E; Tzouvelekis, LS | 1 |
Campos, J; Carrilero, L; Escudero, JA; Garcia-Cobos, S; Gonzalez-Zorn, B; Gutierrez, B; Hidalgo, L; San Millan, A | 1 |
Dal-Ré, R; García-de-Lomas, J; García-Delafuente, C; Iriarte, V; Martín-Herrero, JE; Mazón, A; Pérez-Trallero, E; Robles, P | 1 |
Collins, B; Cotter, PD; Curtis, N; Hill, C; Ross, RP | 1 |
Aldini, G; De Luca, L; Marconi, C; Pedretti, A; Regazzoni, L; Vistoli, G | 1 |
de Waart, DR; Duijst, S; Kunne, C; Oude Elferink, RP; Paulusma, CC; van de Wetering, K | 1 |
Bommareddy, A; Gionfriddo, MR; Heindel, GA; Mukhija, P; Vanwert, AL; Witkowski, S; Wolman, AT | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
5 review(s) available for cefuroxime and cefaclor anhydrous
Article | Year |
---|---|
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumonia; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Pneumonia, Pneumococcal | 1992 |
The cephalosporins: activity and clinical use.
Topics: Cefaclor; Cefamandole; Cefatrizine; Cefazolin; Cefoxitin; Cefuroxime; Cephacetrile; Cephalexin; Cephaloglycin; Cephaloridine; Cephalosporins; Cephalothin; Cephapirin; Drug Hypersensitivity; Humans; Kidney Diseases | 1980 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Management of otitis media. A review.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Child; Humans; Otitis Media; Penicillins; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
15 trial(s) available for cefuroxime and cefaclor anhydrous
Article | Year |
---|---|
Review of the experience with cefprozil for the treatment of lower respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bronchitis; Bronchopneumonia; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Humans; Pneumonia, Pneumococcal | 1992 |
Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogens.
Topics: Administration, Oral; Adult; Cefaclor; Cefuroxime; Haemophilus influenzae; Half-Life; Humans; Intestinal Absorption; Male; Microbial Sensitivity Tests; Moraxella; Pilot Projects; Prodrugs; Streptococcus pneumoniae | 1991 |
[Clinical evaluation of cefuroxime axetil in acute dental infections. Double blind comparative study vs. cefaclor].
Topics: Acute Disease; Adolescent; Adult; Aged; Bacteria; Bacterial Infections; Cefaclor; Cefuroxime; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Jaw Diseases; Male; Middle Aged; Pericoronitis; Periodontitis; Prodrugs | 1990 |
Comparison of cefuroxime axetil, cefaclor, and amoxicillin-clavulanate potassium suspensions in acute otitis media in infants and children.
Topics: Acoustic Impedance Tests; Acute Disease; Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Analysis of Variance; Cefaclor; Cefuroxime; Child; Child, Preschool; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Infant; Male; Otitis Media; Time Factors | 1990 |
Single-dose cefuroxime axetil versus multiple-dose cefaclor in the treatment of acute urinary tract infections.
Topics: Acute Disease; Adult; Blood Chemical Analysis; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Female; Humans; Urinary Tract Infections | 1989 |
Treatment of otitis media with cefuroxime axetil.
Topics: Acute Disease; Cefaclor; Cefuroxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Male; Otitis Media with Effusion; Pharmaceutical Preparations; Prodrugs; Random Allocation | 1988 |
Blinded comparison of cefuroxime to cefaclor for lower respiratory tract infections.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Bacterial Infections; Bronchitis; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Clinical Trials as Topic; Drug Therapy; Female; Humans; Male; Middle Aged; Pneumonia; Prodrugs; Random Allocation; Respiratory Tract Infections | 1988 |
Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefuroxime; Cephalosporins; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Male; Middle Aged; Random Allocation; Urinary Tract Infections | 1987 |
Efficacy and safety of cefprozil versus other beta-lactam antibiotics in the treatment of lower respiratory tract infections.
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Bronchitis; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Multicenter Studies as Topic; Pneumonia; Prodrugs; Randomized Controlled Trials as Topic; Respiratory Tract Infections | 1994 |
Cefuroxime axetil in the treatment of acute sinusitis in childhood.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefuroxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Female; Humans; Male; Pharynx; Sinusitis; Staphylococcus aureus; Streptococcus; Treatment Outcome | 1996 |
Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.
Topics: Acute Disease; Administration, Oral; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Drug Resistance, Microbial; Humans; Infant; Microbial Sensitivity Tests; Otitis Media; Penicillin Resistance; Pneumococcal Infections; Prospective Studies; Streptococcus pneumoniae | 1996 |
Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?
Topics: Acute Disease; Administration, Oral; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Otitis Media; Streptococcus pneumoniae | 1997 |
Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy.
Topics: Administration, Oral; Amoxicillin; Cefaclor; Cefuroxime; Cephalosporins; Child, Preschool; Female; Humans; Male; Otitis Media with Effusion; Penicillin Resistance; Penicillins; Single-Blind Method; Treatment Outcome | 1998 |
Cefaclor and cefuroxime axetil in the treatment of otitis media--an alternative view.
Topics: Biomarkers; Cefaclor; Cefuroxime; Cephalosporins; Child; Humans; Otitis Media; Prodrugs; Random Allocation | 1998 |
Comparative study of cefaclor AF vs. cefuroxime axetil in acute exacerbations of chronic bronchitis.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis, Chronic; Cefaclor; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Single-Blind Method; Time Factors; Treatment Outcome | 2002 |
72 other study(ies) available for cefuroxime and cefaclor anhydrous
Article | Year |
---|---|
[Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
Topics: Anti-Bacterial Agents; Cefaclor; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Escherichia coli; Klebsiella; Proteus mirabilis; Species Specificity | 1979 |
[The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's tr
Topics: Cefaclor; Cefamandole; Cefoxitin; Cefuroxime; Cephalosporins; Cephalothin; Drug Resistance, Microbial; Escherichia coli; Klebsiella; Microbial Sensitivity Tests; Proteus mirabilis | 1979 |
[Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
Topics: Bacteria; Cefaclor; Cefamandole; Cefazolin; Cefoxitin; Cefuroxime; Cephalexin; Cephalosporins; Cephalothin; Enterobacteriaceae; Escherichia coli; Humans; In Vitro Techniques; Pseudomonas | 1979 |
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Topics: beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1992 |
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Drug Evaluation, Preclinical; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 1992 |
Killing kinetics of five orally administered antibiotics at clinically achievable concentrations against Moraxella catarrhalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Child; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Combinations; Drug Therapy, Combination; Erythromycin; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis | 1992 |
Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.
Topics: Ampicillin; Cefaclor; Cefamandole; Cefonicid; Cefuroxime; Cephalosporins; Evaluation Studies as Topic; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control; Reference Standards | 1992 |
Candida laryngotracheitis: a complication of combined steroid and antibiotic usage in croup.
Topics: Amphotericin B; Candidiasis; Candidiasis, Oral; Cefaclor; Cefuroxime; Croup; Dexamethasone; Female; Humans; Infant; Ketoconazole; Laryngitis; Tracheitis | 1992 |
[In vitro activity of cefuroxime against Moraxella (Branhamella) catarrhalis].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefuroxime; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; In Vitro Techniques; Moraxella catarrhalis | 1991 |
Outpatient management of febrile illness in infants and young children with sickle cell anemia.
Topics: Age Factors; Anemia, Sickle Cell; Anti-Bacterial Agents; Bacterial Infections; Body Temperature; Cefaclor; Ceftriaxone; Cefuroxime; Child, Preschool; Cost-Benefit Analysis; Female; Fever; Humans; Infant; Infant, Newborn; Male; Outpatients; Penicillins | 1990 |
Susceptibility of Haemophilus influenzae to antimicrobial agents used in Canada. Canadian Study Group.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Canada; Cefaclor; Cefamandole; Cefazolin; Cefotaxime; Cefuroxime; Chloramphenicol; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Enzyme Inhibitors; Erythromycin; Haemophilus influenzae; Rifampin; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
[Comparative antibacterial activity of cefpodoxime, cefuroxime and cefaclor against strict anaerobic bacteria].
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Cefaclor; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalexin; Cephalosporins; Dose-Response Relationship, Drug; In Vitro Techniques | 1990 |
Comparative evaluation of cefuroxime axetil and cefaclor for treatment of acute bacterial maxillary sinusitis.
Topics: Acute Disease; Adult; Aged; Bacterial Infections; beta-Lactamases; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Drug Evaluation; Female; Haemophilus influenzae; Humans; Male; Maxillary Sinusitis; Middle Aged; Moraxella catarrhalis; Prodrugs; Streptococcus pneumoniae | 1989 |
Antimicrobial activities and susceptibility testing considerations of ampicillin, cephalothin, cefaclor, and cefuroxime against invasive isolates of Haemophilus influenzae.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Cephalothin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillin Resistance | 1989 |
In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
Topics: Acinetobacter; Amoxicillin; Bacteria; Cefaclor; Cefmenoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1987 |
Comparative in vitro activity of the new quinolone fleroxacin (RO 23-6240).
Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Cefaclor; Ceftazidime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Corynebacterium; Drug Combinations; Drug Resistance, Microbial; Fleroxacin; Norfloxacin; Pefloxacin; Piperacillin; Staphylococcus; Vancomycin | 1988 |
In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Topics: Administration, Oral; Cefaclor; Cefixime; Cefotaxime; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseria meningitidis; Streptococcus | 1988 |
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acids; Culture Media; Drug Combinations; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
In vitro activities of LY163892, cefaclor, and cefuroxime.
Topics: Anti-Bacterial Agents; Bacteria; Cefaclor; Cefuroxime; Cephalexin; Cephalosporins; Drug Stability; Temperature | 1988 |
In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.
Topics: Amoxicillin; Ampicillin; beta-Lactamases; Cefaclor; Cefuroxime; Cephaloridine; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseriaceae; Penicillin G | 1986 |
Antimicrobial activity of Ro 15-8074, active metabolite of a new oral cephalosporin (Ro 15-8075), against 7,775 recent clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Ceftizoxime; Cefuroxime; Cephalosporins; Enterobacteriaceae; Humans; Microbial Sensitivity Tests; Plasmids; Pseudomonas; Staphylococcus | 1986 |
Onset of Hemophilus influenzae type-b meningitis during cefaclor therapy for preseptal cellulitis.
Topics: Cefaclor; Ceftriaxone; Cefuroxime; Cellulitis; Cephalexin; Drug Resistance, Microbial; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Male; Meningitis, Haemophilus; Sepsis | 1987 |
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteria.
Topics: Amoxicillin; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalexin; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Escherichia coli; In Vitro Techniques; Pseudomonas; Staphylococcus | 1986 |
Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; beta-Lactamases; beta-Lactams; Cefaclor; Cefoperazone; Cefotaxime; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Cephamycins; Culture Media; Microbial Sensitivity Tests; Moxalactam | 1980 |
A comparison of the activity in vitro of different cephalosporins: cephalothin, cephradine, cephacetrile, cefaclor, cefuroxime and cefotaxime.
Topics: Cefaclor; Cefotaxime; Cefuroxime; Cephacetrile; Cephalosporins; Cephalothin; Cephradine; Enterobacter; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 1980 |
Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Dose-Response Relationship, Drug; Doxycycline; Drug Combinations; Erythromycin; Haemophilus influenzae; Humans; Neisseria; Penicillin Resistance; Penicillin V; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
Benefits and risks of sequential parenteral--oral cephalosporin therapy for suppurative bone and joint infections.
Topics: Acute Disease; Administration, Oral; Arthritis, Infectious; Bacterial Infections; Cefaclor; Cefamandole; Cefuroxime; Cephalexin; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infusions, Parenteral; Male; Osteoarthritis; Osteomyelitis; Suppuration | 1982 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; beta-Lactamases; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Resistance, Multiple; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests | 1994 |
Variation in acceptance of common oral antibiotic suspensions.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Child, Preschool; Female; Humans; Infant; Israel; Male; Otitis Media; Patient Compliance; Surveys and Questionnaires; Suspensions; Taste; Trimethoprim, Sulfamethoxazole Drug Combination | 1994 |
Evaluation of the E test for antimicrobial susceptibility testing of Porphyromonas gingivalis.
Topics: Ampicillin; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Doxycycline; Erythromycin; Evaluation Studies as Topic; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Porphyromonas gingivalis; Tetracyclines | 1994 |
In vitro antimicrobial susceptibility of different serotypes of Actinobacillus actinomycetemcomitans.
Topics: Aggregatibacter actinomycetemcomitans; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Cefaclor; Cefuroxime; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Metronidazole; Penicillin G; Penicillin Resistance; Serotyping; Tetracycline; Tetracycline Resistance; Trimethoprim, Sulfamethoxazole Drug Combination | 1993 |
Analytical investigation of beta-lactam antibiotics in pharmaceutical preparations. IX. Colorimetric determination of six cephalosporins of second and third generation in the range of micromolar concentrations.
Topics: Cefaclor; Cefamandole; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Colorimetry; Indicators and Reagents; Molecular Structure; Sensitivity and Specificity | 1996 |
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Moraxella catarrhalis; Penicillins; Sicily; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 1996 |
In vitro susceptibilities of 180 clinical isolates of Haemophilus influenzae to ampicillin, amoxycillin/clavulanate, cefaclor, cefuroxime, cefotaxime, clarithromycin, and azithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefotaxime; Cefuroxime; Child; Child, Preschool; Clarithromycin; Clavulanic Acids; Cross Infection; Haemophilus Infections; Haemophilus influenzae; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Middle Aged | 1996 |
Antimicrobial susceptibility of Streptococcus pneumoniae isolated from pediatric carriers in Spain.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Carrier State; Cefaclor; Cefuroxime; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Erythromycin; Humans; Infant; Microbial Sensitivity Tests; Penicillins; Spain; Streptococcus pneumoniae; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
In vitro activities of oral antimicrobial agents against penicillin-resistant Streptococcus pneumoniae: implications for outpatient treatment.
Topics: Administration, Oral; Adult; Ambulatory Care; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefprozil; Cefuroxime; Cephalosporins; Child; Clarithromycin; Clindamycin; Culture Media; Humans; Penicillin Resistance; Pneumococcal Infections; Streptococcus pneumoniae; Tetracycline; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; beta-Lactam Resistance; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Protein Binding; Streptococcus pneumoniae | 1997 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
The effects of the morphological response of Enterobacteriaceae to cephalosporins on PAE and CERT.
Topics: Cefaclor; Cefuroxime; Cephalosporins; Colony Count, Microbial; Culture Media; Electric Impedance; Enterobacteriaceae; Luminescent Measurements; Microbial Sensitivity Tests | 1998 |
Classification of Streptococcus pneumoniae based on in-vitro susceptibility to oxyiminocephalosporins.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefotiam; Cefuroxime; Cephalosporins; Humans; Japan; Microbial Sensitivity Tests; Penicillin G; Streptococcus pneumoniae | 1999 |
Evaluation of oral antimicrobial agent levels in tooth extraction sites.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alveolar Process; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefmenoxime; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Ofloxacin; Penicillins; Prodrugs; Staphylococcal Infections; Streptococcus; Talampicillin; Time Factors; Tooth Diseases; Tooth Extraction; Tooth Socket | 2001 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |
Reassessment of the cefaclor breakpoint for Streptococcus pneumoniae.
Topics: Anti-Bacterial Agents; Cefaclor; Cefuroxime; Humans; Microbial Sensitivity Tests; Streptococcus pneumoniae | 2004 |
Reassessment of cefaclor breakpoints for Haemophilus influenzae.
Topics: Cefaclor; Cefuroxime; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Sampling Studies; Sensitivity and Specificity; United Kingdom | 2004 |
[Susceptibility of Branhamella catarrhalis to antibiotics].
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefotaxime; Cefuroxime; Ciprofloxacin; Clavulanic Acids; Drug Combinations; Erythromycin; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 2004 |
A comparison of the safety and efficacy of cefuroxime axetil and cefaclor in outpatient management of community-acquired lower respiratory tract infections.
Topics: Alabama; Anti-Bacterial Agents; Bronchitis; Cefaclor; Cefuroxime; Clinical Trials as Topic; Community-Acquired Infections; Drug Combinations; Humans; Pneumonia, Bacterial; Reproducibility of Results; Respiratory Tract Infections; Safety; Treatment Failure; Treatment Outcome | 1989 |
In vitro antimicrobial activity of cefditoren and other oral antibiotics against Streptococcus pneumoniae, isolated from children with community acquired respiratory tract infections.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefuroxime; Cephalosporins; Child; Child, Preschool; Community-Acquired Infections; Drug Resistance, Bacterial; Humans; Korea; Respiratory Tract Infections; Streptococcus pneumoniae | 2010 |
Study on the binding behavior of bovine serum albumin with cephalosporin analogues by chemiluminescence method.
Topics: Animals; Anti-Bacterial Agents; Cattle; Cefaclor; Cefadroxil; Cefazolin; Cefoperazone; Cefotaxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Luminescence; Luminescent Measurements; Phthalic Acids; Serum Albumin, Bovine; Thermodynamics; Tryptophan | 2010 |
Evaluation of disk diffusion methods to detect low-level β-lactamase-negative ampicillin-resistant Haemophilus influenzae.
Topics: Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefuroxime; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Genotype; Haemophilus influenzae; Microbial Sensitivity Tests; Regression Analysis | 2011 |
Characterization and antibiotic susceptibility of Streptococcus agalactiae isolates causing urinary tract infections.
Topics: Anti-Bacterial Agents; Cefaclor; Ceftriaxone; Cefuroxime; Disk Diffusion Antimicrobial Tests; DNA Gyrase; Drug Resistance, Bacterial; Erythromycin; Humans; Levofloxacin; Penicillins; Streptococcal Infections; Streptococcus agalactiae; Tetracycline; Urinary Tract Infections | 2015 |
New N-substituted 7-aminocephalosporanic acid derivatives as potential agents against Streptococcus pneumoniae. Synthesis and in vitro activity.
Topics: Anti-Bacterial Agents; Cephalosporins; Microbial Sensitivity Tests; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes; Structure-Activity Relationship | 1999 |
Interaction of 31 beta-lactam antibiotics with the H+/peptide symporter PEPT2: analysis of affinity constants and comparison with PEPT1.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Binding Sites; Caco-2 Cells; Dose-Response Relationship, Drug; Humans; Peptide Transporter 1; Protein Binding; Rats; Symporters | 2005 |
Three-dimensional quantitative structure-activity relationship analyses of beta-lactam antibiotics and tripeptides as substrates of the mammalian H+/peptide cotransporter PEPT1.
Topics: Animals; beta-Lactams; Cell Line, Tumor; Dipeptides; Drug Design; Humans; Mammals; Models, Molecular; Oligopeptides; Peptide Transporter 1; Quantitative Structure-Activity Relationship; Substrate Specificity; Symporters | 2005 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea.
Topics: Ampicillin Resistance; beta-Lactamases; Drug Resistance, Bacterial; Genes, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Korea; Microbial Sensitivity Tests; Mutation; Penicillin-Binding Proteins; Species Specificity | 2007 |
Ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime.
Topics: Amino Acid Substitution; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporin Resistance; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Genetic Variation; Haemophilus influenzae; Histidine; Humans; Lysine; Microbial Sensitivity Tests; Molecular Epidemiology; Polymerase Chain Reaction; Sequence Analysis, DNA; Spain | 2007 |
Can the Etest correctly determine the MICs of beta-lactam and cephalosporin antibiotics for beta-lactamase-negative ampicillin-resistant Haemophilus influenzae?
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cephalosporins; Haemophilus influenzae; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2007 |
Plasmid-encoded ACC-4, an extended-spectrum cephalosporinase variant from Escherichia coli.
Topics: Anti-Bacterial Agents; Cephalosporinase; Culture Media; DNA Primers; Drug Resistance, Bacterial; Escherichia coli; Kinetics; Models, Molecular; Molecular Sequence Data; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Spectrophotometry, Ultraviolet | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Genotypic versus phenotypic characterization, with respect to beta-lactam susceptibility, of Haemophilus influenzae isolates exhibiting decreased susceptibility to beta-lactam resistance markers.
Topics: Bacterial Proteins; beta-Lactam Resistance; beta-Lactams; Genotype; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Mutation; Phenotype | 2009 |
Relative strengths of the class 1 integron promoter hybrid 2 and the combinations of strong and hybrid 1 with an active p2 promoter.
Topics: beta-Lactamases; beta-Lactams; Integrons; Microbial Sensitivity Tests; Promoter Regions, Genetic; Pseudomonas aeruginosa | 2009 |
Extended-spectrum properties of CMY-30, a Val211Gly mutant of CMY-2 cephalosporinase.
Topics: Aztreonam; beta-Lactamases; beta-Lactams; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Protein Binding; Protein Structure, Secondary | 2009 |
Discovery of new inhibitors of resistant Streptococcus pneumoniae penicillin binding protein (PBP) 2x by structure-based virtual screening.
Topics: Computational Biology; Computer Simulation; Drug Discovery; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Ligands; Penicillin-Binding Proteins; Protein Binding; Streptococcus pneumoniae; Structure-Activity Relationship | 2009 |
Antimicrobial resistance in Haemophilus influenzae respiratory tract isolates in Korea: results of a nationwide acute respiratory infections surveillance.
Topics: Adolescent; Adult; Aged; Amino Acid Sequence; Amino Acid Substitution; Ampicillin; Ampicillin Resistance; beta-Lactamases; Child; Child, Preschool; DNA, Bacterial; Drug Resistance, Bacterial; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Penicillin-Binding Proteins; Population Surveillance; Respiratory Tract Infections; Reverse Transcriptase Polymerase Chain Reaction; Serotyping; Young Adult | 2010 |
GES-13, a beta-lactamase variant possessing Lys-104 and Asn-170 in Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; Aztreonam; beta-Lactamases; beta-Lactams; Cephalosporins; Genetic Variation; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Analysis, DNA | 2010 |
Haemophilus influenzae clinical isolates with plasmid pB1000 bearing blaROB-1: fitness cost and interspecies dissemination.
Topics: Animals; beta-Lactamases; Cefaclor; Conjugation, Genetic; Drug Resistance, Bacterial; Haemophilus Infections; Haemophilus influenzae; Humans; Molecular Epidemiology; Molecular Sequence Data; Pasteurella multocida; Plasmids; Replicon; Spain; Species Specificity; Transformation, Genetic | 2010 |
Antimicrobial resistance among respiratory pathogens in Spain: latest data and changes over 11 years (1996-1997 to 2006-2007).
Topics: Ampicillin; Anti-Bacterial Agents; Cefotaxime; Erythromycin; Haemophilus influenzae; Lincosamides; Macrolides; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Spain; Streptococcus pneumoniae; Streptococcus pyogenes; Streptogramin B | 2010 |
The ABC transporter AnrAB contributes to the innate resistance of Listeria monocytogenes to nisin, bacitracin, and various beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; ATP-Binding Cassette Transporters; Bacitracin; Bacterial Proteins; beta-Lactam Resistance; Listeria monocytogenes; Nisin | 2010 |
Fragmental modeling of hPepT2 and analysis of its binding features by docking studies and pharmacophore mapping.
Topics: Binding Sites; Computer Simulation; Drug Design; Humans; Ligands; Models, Molecular; Peptides; Protein Binding; Structural Homology, Protein; Symporters | 2011 |
Oral availability of cefadroxil depends on ABCC3 and ABCC4.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Biological Transport; Cefadroxil; Cell Membrane; Enterocytes; Estradiol; Intestinal Absorption; Intestinal Mucosa; Jejunum; Mice; Mice, Knockout; Multidrug Resistance-Associated Proteins | 2012 |
Organic anion transporter 3 interacts selectively with lipophilic β-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biological Transport; Cell Line, Transformed; Humans; Mice; Organic Anion Transport Protein 1; Organic Anion Transporters, Sodium-Independent; Solubility; Structure-Activity Relationship | 2013 |